POST-TEST:  New Medications Released During 2004 (Evaluation Form Found Below)

 

1.       The medications used in pain management are often seen in the management of what other conditions?

a.        epilepsy

b.      depression

c.       diabetes

d.      a & b

e.      All of the above

2.       Lyrica (pregabalin) is used for postherpetic neuralgia pain which is caused by:

a.       shingles

b.      osteoporosis

c.       overactive bladder

d.      severe refractory pain

3.      The route used for the oncology drug Vidaza (azaciatidine) in myelodyplastic syndrome is:

a.       oral

b.      IV

c.       Subcutaneous

d.      hypodermoclysis

4.      The oncology drug that uses the epidermal growth factor receptor (EGFR) for expressing metastatic colorectal cancer is:

a.       Avastin (bevacizumab)

b.      Erbitux (cetuximab)

c.       Altimta (pemetrexed disodium)

d.      Sanctura (trospium chloride)

5.      Avastin (bevacizumab) is used for:

a.       acute lymphocytic leukemia (ALL)

b.      metastatic colorectal carcinoma

c.       malignant pleural mesothelioma

d.      non-small cell lung cancer (NSCLC)

6.      Which new oncology drug needs a vitamin B 12 injection every nine (9) weeks?

a.       Tarceva (erlotinib)

b.      Altimta (pemetrexed disodium)

c.       Vidaza (azaciatidine)

d.      Clolar (clofarabine)

7.      Campral (acamprosate calcium)is

a.        the first drug of its category.

b.      used for major depression.

c.       considered for the patient that has been abstinent for 1-3 years.

d.      given on a QID time schedule.

8.      List 2 resources available to access information about medications.

a.       

b.       

Bonus:  What drugs discussed will only be given in the doctor’s office?

 

 

EVALUATION:  New Medications Released During 2004            

                The purpose of this course is to enrich the nurse’s and other health care professionals contribution to quality health care and the pursuit of professional career goals by updating the nurse on the changes in the new molecular entities and biological products that were licensed in 2004 so as to improve medication administration and decision making.

 

1.        The following objectives were met.

 

a. Identify the trade or generic name, classification, dosage/delivery fact or nursing action/safety precaution that you will take during administration of each of the new drugs that have appeared on the market during the year of 2004.

1.             2.             3.             4.             5.

 

b. List the conditions that the new pain medications can be used for concurrently.

1.             2.             3.             4.             5.

 

c. Identify the unique characteristics of the three (3) new drugs for cancer and what types of cancer they are being used for.

1.             2.             3.             4.             5.

 

d. Discuss the use of the new biologic entity for Alcohol Dependence.

1.             2.             3.             4.             5.

 

       e. List the resources available to access information about medications.

1.             2.             3.             4.             5.

 

2.     Rate the effectiveness of the teaching/learning resources.

                1.             2.             3.             4.             5.

 

3.     Rate the relationship of the objectives to the overall purpose of the activity.

1.             2.             3.             4.             5.

 

4.     Guest Speaker- Renee Acosta, RPh , MS

a.        Knowledge and currency of topic.

1.             2.             3.             4.             5.

b.       Ability to make points clear.

1.             2.             3.             4.             5.

c.        Ability to apply content to practice.

1.             2.             3.             4.             5.

d.       Speaking Style.

1.             2.             3.             4.             5.

 

5.     Moderator – Elizabeth Huss, RN, BSN

e.        Guides the discussion.

1.             2.             3.             4.             5.

f.         Asks pertinent questions.

1.             2.             3.             4.             5.

g.       Encourages attention to subject matter

1.             2.             3.             4.             5.

h.       Fosters clarification of presented information.

1.             2.             3.             4.             5.

i.         Fosters relaxed attentiveness.

1.             2.             3.             4.             5.